Last reviewed · How we verify
Axid
At a glance
| Generic name | Axid |
|---|---|
| Sponsor | Dr. Reddy's Laboratories Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19
- Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis (PHASE4)
- [KJ-INT-002] BE Study (PHASE1)
- Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss (NA)
- Prophylaxis for Aspiration of Gastric Contents. (PHASE4)
- Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
- Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects (PHASE1)
- Drug-Drug Interaction Study With Metformin and Nizatidine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Axid CI brief — competitive landscape report
- Axid updates RSS · CI watch RSS
- Dr. Reddy's Laboratories Limited portfolio CI